Alpha Tau Medical Ltd
DRTSW0.330USD
0.000
Close （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of Alpha Tau Medical Ltd Company
Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.
Alpha Tau Medical Ltd Info
Ticker SymbolDRTSW
Company nameAlpha Tau Medical Ltd
IPO dateMar 08, 2022
CEOMr. Uzi Sofer
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
AddressKiryat Hamada 5
CityJERUSALEM
Stock exchangeNASDAQ Capital Market Consolidated
CountryIsrael
Postal code9777605
Phone97235774115
Websitehttps://www.alphatau.com/
Ticker SymbolDRTSW
IPO dateMar 08, 2022
CEOMr. Uzi Sofer
Company Executives of Alpha Tau Medical Ltd
Name
Name/Position
Position
Shareholding
Change
DR. David Mark Milch
DR. David Mark Milch
Director
Director
--
--
Mr. Peter M. Melnyk
Mr. Peter M. Melnyk
Independent Director
Independent Director
--
--
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Alan Adler
Mr. Alan Adler
Independent Director
Independent Director
--
--
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ronen Segal
Mr. Ronen Segal
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Robert Den, M.D.
Dr. Robert Den, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Maya Netser
Ms. Maya Netser
Director
Director
--
--
Mr. Michael Avruch
Mr. Michael Avruch
Independent Director
Independent Director
--
--
Ms. Ruth Alon
Ms. Ruth Alon
Director
Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
DR. David Mark Milch
DR. David Mark Milch
Director
Director
--
--
Mr. Peter M. Melnyk
Mr. Peter M. Melnyk
Independent Director
Independent Director
--
--
Prof. Yona Keisari
Prof. Yona Keisari
Chief Scientific Officer
Chief Scientific Officer
--
--
Mr. Alan Adler
Mr. Alan Adler
Independent Director
Independent Director
--
--
Mr. Uzi Sofer
Mr. Uzi Sofer
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Ronen Segal
Mr. Ronen Segal
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
38
3.58M
0.00%
--
2025Q3
39
3.58M
0.00%
+18.79K
2025Q2
39
3.56M
0.00%
+155.22K
2025Q1
43
3.40M
0.00%
-864.83K
2024Q4
45
3.65M
0.00%
+24.78K
2024Q3
49
3.62M
0.00%
-190.67K
2024Q2
52
3.87M
0.00%
-19.80K
2024Q1
52
3.89M
0.00%
-1.15M
2023Q4
50
3.80M
0.00%
-100.95K
2023Q3
50
3.89M
0.00%
-166.49K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
UBS Financial Services, Inc.
28.39K
0%
+17.81K
+168.43%
Jun 30, 2025
Corbin Capital Partners, L.P.
960.48K
0%
--
--
Dec 31, 2024
MMCAP Asset Management
447.62K
0%
--
--
Jun 30, 2025
Atalaya Capital Management LP
280.47K
0%
--
--
Jun 30, 2024
Chicago Partners Wealth Advisors
215.82K
0%
--
--
Jun 30, 2025
Moore Capital Management, LP
175.00K
0%
--
--
Jun 30, 2025
Value Base
152.76K
0%
--
--
Jun 30, 2025
Tenor Capital Management Co., L.P.
150.00K
0%
--
--
Jun 30, 2025
Whitebox Advisors, L.L.C.
136.02K
0%
--
--
Jun 30, 2025
LMR Partners LLP
112.99K
0%
--
--
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
SPAC and New Issue ETF
0%
SPAC and New Issue ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Alpha Tau Medical Ltd?
The top five shareholders of Alpha Tau Medical Ltd are:
UBS Financial Services, Inc. holds 28.39K shares, accounting for 0.00% of the total shares.
Corbin Capital Partners, L.P. holds 960.48K shares, accounting for 0.00% of the total shares.
MMCAP Asset Management holds 447.62K shares, accounting for 0.00% of the total shares.
Atalaya Capital Management LP holds 280.47K shares, accounting for 0.00% of the total shares.
Chicago Partners Wealth Advisors holds 215.82K shares, accounting for 0.00% of the total shares.
UBS Financial Services, Inc. holds 28.39K shares, accounting for 0.00% of the total shares.
Corbin Capital Partners, L.P. holds 960.48K shares, accounting for 0.00% of the total shares.
MMCAP Asset Management holds 447.62K shares, accounting for 0.00% of the total shares.
Atalaya Capital Management LP holds 280.47K shares, accounting for 0.00% of the total shares.
Chicago Partners Wealth Advisors holds 215.82K shares, accounting for 0.00% of the total shares.
What are the top three shareholder types of Alpha Tau Medical Ltd?
The top three shareholder types of Alpha Tau Medical Ltd are:
Other
Other
How many institutions hold shares of Alpha Tau Medical Ltd (DRTSW)?
As of 2025Q4, 38 institutions hold shares of Alpha Tau Medical Ltd, with a combined market value of approximately 3.58M, accounting for --% of the total shares. Compared to 2025Q3, institutional shareholding has increased by --.
What is the biggest source of revenue for Alpha Tau Medical Ltd?
In --, the -- business generated the highest revenue for Alpha Tau Medical Ltd, amounting to -- and accounting for --% of total revenue.
